David Hydock

Faculty

Professor & Department Chair

Email David.hydock@unco.edu
Phone 970-351-3053
Location Gunter Hall
Address 501 20th St., Campus Box 39 Greeley, CO 80639

Education

Postdoctoral Research Fellowship, University of Northern Colorado, 2007
Area of Study: Exercise Physiology, Cardiovascular Physiology, Cancer Rehabilitation

PhD, University of Northern Colorado, 2005
Area of Study: Exercise Physiology

MAT, Northern State University, 1996
Area of Study: Health and Physical Education

BA, Adams State University, 1995
Area of Study: English

 

Professional Experience & Affiliations

Professor and Chair, University of Northern Colorado
Department of Kinesiology, Nutrition, and Dietetics (KiND) (2021-Present)

Professor, University of Northern Colorado
(2019-2021)

Associate Professor, University of Northern Colorado
(2014-2019)

Assistant Professor, University of Northern Colorado
(2009-2014)

Lecturer, University of Northern Colorado
(2008-2009)

Research Associate, University of Northern Colorado
(2007-2008)

Postdoctoral Research Fellow, University of Northern Colorado
(2005-2007)

Program Manager, University of Northern Colorado
Rocky Mountain Cancer Rehabilitation Institute (2004)

Graduate Assistant, University of Northern Colorado
(2001-2004)

Head Strength and Conditioning Coach/Adjunct Instructor, North Dakota State College of Science
(1999-2001)

Adjunct Instructor, University of Mary
(1998-1999)

Exercise Physiologist, Medcenter One Health Systems
(1996-1999)

 

Research Expertise & Interests

Areas of Interest

Effects of exercise and nutrition interventions on cancer treatment toxicities.

Transgender physical activity and health.

Publications

  • Kugler BA, Capps MJ, Hydock DS. Protection against late-onset doxorubicin myotoxicity using creatine and resistance exercise. Medical Research Archives 10 (6), 2022.
  • Hydock DS. Sex hormone suppression and physical activity: possible implications for transgender individuals. Transgender Health 7: 43-51, 2022.
  • Aljobaily N, Viereckl M, Hydock DS, Aljobaily H, Busekrus R, Jones B, Han Y. Creatine alleviates doxorubicin-induced liver damage by inhibiting cellular senescence, oxidative-induced inflammation, and liver fibrosis. Nutrients 13 (41), 2020.
  • Bredahl EC, Sharif S, Siedlik JA, Wagner MK, Twaddell MD, Tigner AT, Dovgan MD, Najdawi WO,Hydock DS, Eckerson JM, Drescher KM. Resistance training during chemotherapy with doxorubicin. Medicine and Science in Sport and Exercise 52: 2529-2537, 2020.
  • Dinger MK, Brittain DR, Patten L, Hall KC, Burton S, Hydock DS, Stellino MB. Gender identity and health-related outcomes in a national sample of college students. American Journal of Health Education 51: 383-394, 2020.
  • Bredahl EC, Busekrus RB, Hydock DS. The combined effects of creatine and resistance training on doxorubicin-induced muscle dysfunction. Nutrition and Cancer 72: 939-947, 2020.
  • Torok ZA, Busekrus RL, Hydock DS. Effects of creatine supplementation on muscle fatigue in rats receiving doxorubicin. Nutrition and Cancer 72: 252-259, 2020.
  • Hochberg LM, Busekrus RL, Hydock DS. The effects of wheel running on skeletal muscle function during and following doxorubicin treatment. Rehabilitation Oncology 37: 114-121, 2019.
  • Dames KD, Heise GD, Hydock DS, Smith JD. Obese adults walk differently in shoes than while barefoot. Gait & Posture 70: 79-83, 2019.
  • Stewart LK, Smoak P, Hydock DS, Hayward R, O’Brien K, Lisano J, Boeneke C, Christensen M, Mathias A. Milk and kefir maintain aspects of health during doxorubicin treatment in rats. Journal of Dairy Science 102: 1910-1917, 2019.
  • Quinn CJ, Hydock DS. Effects of endurance exercise and doxorubicin on skeletal muscle myogenic regulatory factor expression. Muscle, Ligaments and Tendons Journal 7: 418-425, 2017.
  • Sharif S, Elzaydi N, Hydock DS. Analysis of pre-participation screening protocols for football players in Europe, the United States, and Lybia: possible implications for preventing sudden cardiac death. Turkish Journal of Sports Medicine 52: 63-69, 2017.
  • Bredahl EC, Hydock DS. Creatine supplementation and doxorubicin-induced skeletal muscle dysfunction: an ex vivo investigation. Nutrition and Cancer 69: 607- 615, 2017.
  • Quinn CJ, Gibson NM, Pfannenstiel KB, Bashore AC, Hayward R, Hydock DS. Effects of exercise on doxorubicin accumulation and multidrug resistance protein expression in striated muscle. Global Journal of Medical Research 16: 11-22, 2016.
  • Quinn CJ, Burns PD, Gibson NM, Bashore A, Hayward R, Hydock DS. Effects of chronic exercise on doxorubicin-induced thymic damage. Integrative Cancer Therapies 15: 535-541, 2016.
  • Bredahl EC, Quinn CJ, Pfannenstiel KB, Hayward R, Hydock DS. Effects of exercise on acute doxorubicin-induced skeletal muscle dysfunction. Medicine and Science in Sports and Exercise 48: 1468-73, 2016.
  • Lien CY, Jensen BT, Hydock DS, Hayward R. Short-term exercise attenuates acute doxorubicin cardiotoxicity. Journal of Physiology and Biochemistry 71: 668-79, 2015.
  • Parry TL, Hydock DS, Jensen BT, Lien CY, Schneider CM, Hayward R. Endurance exercise attenuates cardiotoxicity induced by androgen deprivation and doxorubicin. Canadian Journal of Physiology and Pharmacology 92: 356-362, 2014.
  • Gibson NM, Quinn CJ, Pfannenstiel KB, Hydock DS, Hayward R. Effects of Age on Multidrug Resistance Protein Expression and Doxorubicin Accumulation in Cardiac and Skeletal Muscle. Xenobiotica 44: 472-479, 2014.
  • Hydock DS, Parry TL, Wymore JD, Iwaniec UT, Turner RT, Schneider CM, Hayward R. Effects of treadmill training on combined goserelin acetate and doxorubicin-induced osteopenia in female rats. Journal of Musculoskeletal and Neuronal Interactions 14: 10-18, 2014.
  • Jensen BT, Lien CY, Hydock DS, Schneider CM, Hayward R. Exercise mitigates cardiac doxorubicin accumulation and preserves function in the rat. Journal of Cardiovascular Pharmacology 62: 263-269, 2013.
  • Hayward R, Hydock DS, Gibson NM, Greufe SE, Bredahl EC, Parry TL. Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function. Journal of Physiology and Biochemistry 69:177-187, 2013.
  • Gibson NM, Greufe SE, Hydock DS, Hayward R. Doxorubicin-induced vascular dysfunction and its attenuation by exercise preconditioning. Journal of Cardiovascular Pharmacology 62: 355-360, 2013.
  • Hydock DS, Lien CY, Jensen BT, Schneider CM, Hayward R. Switching to a low-fat diet attenuates the intensified doxorubicin cardiotoxicity associated with high-fat feeding. Cancer Chemotherapy and Pharmacology 71: 1551-1560, 2013.
  • Sato K, Fortenbaugh D, Hydock DS, Heise GD. Comparison of back squat kinematics between barefoot and shoe conditions. International Journal of Sports Science and Coaching 8: 571-578, 2013.
  • Hayward R, Iwaniec UT, Turner RT, Lien CY, Jensen BT, Hydock DS, Schneider CM. Voluntary wheel running does not protect against doxorubicin-mediated bone degeneration in the growing Sprague Dawley rat. Journal of Pediatric Hematology and Oncology 35: 144-148, 2013.
  • Hydock DS, Lien CY, Jensen BT, Parry TL, Schneider CM, Hayward R. Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity. Experimental Biology and Medicine 237: 1483-1492, 2012.
  • Hayward R, Lien CY, Jensen BT, Hydock DS, Schneider CM. Exercise training mitigates anthracycline-induced chronic cardiotoxicity in a juvenile rat model. Pediatric Blood and Cancer 59: 149-154, 2012.
  • Sato K, Fortenbaugh D, Hydock DS. Kinematic changes using weightlifting shoes on barbell back squat. Journal of Strength and Conditioning Research 26: 28-33, 2012.
  • Hydock DS, Parry TL, Jensen BT, Lien CY, Schneider CM, Hayward R. Effects of endurance training on combined goserelin acetate and doxorubicin treatment-induced cardiac dysfunction. Cancer Chemotherapy and Pharmacology 68: 685-629, 2011.
  • Hydock DS, Lien, CY, Jensen, BT, Schneider, CM, Hayward, R. Characterization of the effects of in vivo doxorubicin treatment on skeletal muscle function in the rat. Anticancer Research 31: 2023-2028, 2011.
  • Hydock DS, Lien, CY, Jensen, BT, Schneider, CM, Hayward, R. Exercise preconditioning provides long-term protection against early chronic doxorubicin cardiotoxicity. Integrative Cancer Therapies 10: 47-57, 2011.
  • Hydock DS, Wonders KY, Schneider CM, Hayward R. Voluntary wheel running in rats receiving doxorubicin: effects on running activity and cardiac myosin heavy chain. Anticancer Research 29: 4401-4407, 2009.
  • Wonders KY, Hydock DS, Greufe, S, Schneider, CM, Hayward, R. Endurance training preserves cardiac function in rats receiving doxorubicin and the HER-2 inhibitor GW2974. Cancer Chemotherapy and Pharmacology 64: 1105-1113, 2009
  • Hydock DS, Lien CY, Schneider CM, Hayward R. Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model. Journal of Cardiovascular Pharmacology and Therapeutics 14: 59-67, 2009.
  • Hydock DS, Iwaniec UT, Turner RT, Lien CY, Jensen BT, Parry TL, Hayward R. Effects of voluntary wheel running on goserelin acetate-induced bone degeneration. Pathophysiology 15: 253-259, 2008.
  • Wonders KY, Hydock DS, Schneider CM, Hayward R. Acute exercise protects against doxorubicin cardiotoxicity. Integrative Cancer Therapies 7: 147-154, 2008.
  • Hsieh CC, Sprod, LK, Hydock DS, Carter SD, Hayward R, Schneider CM. Effects of a supervised exercise intervention on recovery from treatment regimens in breast cancer survivors. Oncology Nursing Forum 35: 909-915, 2008.
  • Hydock DS, Lien CY, Schneider CM, Hayward R. Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction by preserving myosin heavy chain composition. Medicine and Science in Sports and Exercise 40: 808-817, 2008.
  • Hydock DS, Lien CY, Schneider CM, Hayward R. Effects of voluntary wheel running on cardiac function and myosin heavy chain in chemically gonadectomized rats. American Journal of Physiology-Heart and Circulatory Physiology 293: H3254- H3264, 2007
  • Wonders KY, Hydock DS, Hayward R. Time-course of changes in cardiac function during recovery after acute exercise. Applied Physiology, Nutrition, and Metabolism 32: 1164-1169, 2007.
  • Hayward R, Hydock DS. Doxorubicin cardiotoxicity in the rat: an in vivo characterization. Journal of the American Association for Laboratory Animal Science 46: 20-32, 2007
  • Hydock DS, Wonders KY, Schneider CM, Hayward R. Androgen deprivation therapy and cardiac function: effects of endurance training. Prostate Cancer and Prostatic Diseases 9: 392-398, 2006.
  • Chicco A, Hydock DS, Schneider CM, Hayward R. Low intensity exercise training protects against doxorubicin cardiotoxicity. Journal of Applied Physiology 100: 519- 527, 2006.
  • Hydock DS. The weightlifting pull in power development. Strength and Conditioning Journal 23: 32-37, 2001.
  • Hydock DS. The split position: sport specificity with a barbell. Strength and Conditioning 19: 56-59, 1997.
  • Wong D, Babkes Stellino M, Hydock D. Transgender College Student Physical Activity and Mental Health: Increasing Awareness for Interventions. Association for Applied Sport Psychology 36th Annual Conference, 2021.
  • Sharif S, Jones BC, Busekrus RB, Hydock DS. Effects of creatine supplementation before doxorubicin treatment on the phosphocreatine system in cardiac muscle. American College of Sports Medicine Annual Meeting, 2021. Medicine & Science in Sports & Exercise. 53: S478, 2021.
  • Jones BC, Haughian JM, Hydock DS. Creatine supplementation does not alter proliferation or doxorubicin sensitivity of mammary carcinoma cells. Experimental Biology Meeting, 2021, The Journal of the Federation of American Societies for Experimental Biology 35: S1, 2021
  • Jones BC, Busekrus RB, Sharif S, Hydock DS. Examination of the time course effect of creatine supplementation on acute doxorubicin-induced skeletal muscle dysfunction. Poster Presentation, American College of Sports Medicine Annual Meeting, 2020 (Abstract Only). Medicine & Science in Sports & Exercise. 52: S115, 2020.
  • Busekrus RB, Jones BC, Hydock DS. Myogenic regulatory factor expression time course following doxorubicin injection in rats supplemented with dietary creatine. American College of Sports Medicine Annual Meeting, 2020 (Abstract Only). Medicine & Science in Sports & Exercise. 52: S718, 2020.
  • Viereckl M, Aljobaily NA, Hydock DS, Han Y. Creatine administration alleviates doxorubicin-induced liver damage by inhibiting senescence and inflammation related pathways. The Liver Meeting, Virtual, 2020.
  • Aljobaily NA, Viereckl M, Aljobaily HA, Albertson JA, Han Y, Hydock D. Role of Creatine supplementation in alleviating hepatotoxicity caused by doxorubicin. Experimental Biology Meeting 2020 (Abstract Only). The Journal of the Federation of American Societies for Experimental Biology 34: S1, 2020.
  • Sharif S, Hydock DS, Daehlin KA, Twaddle MD, Tigner AT, Wagner MK, Bredahl EC. Resistance exercise and doxorubicin treatment: effects on antioxidant enzyme expression in type II muscle. Poster Presentation, American College of Sports Medicine Annual Meeting, Orlando, FL, 2019. Medicine & Science in Sports & Exercise. 51: S397, 2019.
  • Busekrus RL, Torok ZA, Hydock DS. Effects of the anticancer drug doxorubicin and dietary creatine supplementation on myogenic regulatory factor expression. Poster Presentation, Experimental Biology Meeting, Orlando, FL, 2019. The Journal of the Federation of American Societies for Experimental Biology 33: S539.6, 2019.
  • Torok ZA, Busekrus RL, Hydock DS. Effects of two creatine monohydrate feeding protocols on doxorubicin-induced skeletal muscle dysfunction. Poster Presentation, Experimental Biology Meeting, Orlando, FL, 2019. The Journal of the Federation of American Societies for Experimental Biology 33: S868.16, 2019.
  • Sharif S, Hydock DS, Twaddle M, Tigner A, Wagner M, Bredahl EC. Doxorubicin, Resistance Training, and Type I Muscle: Effects on Creatine Kinase and Creatine Transporter. Poster Presentation, American College of Sports Medicine Conference on Integrative Physiology of Exercise, San Diego, CA, Presentation #159, 2018.
  • Sharif S, Hydock DS, Twaddle M, Tigner A, Wagner M, Bredahl EC. Effects of resistance training and doxorubicin on creatine transporter and creatine kinase expression in fast muscle. Poster Presentation, American College of Sports Medicine Annual Meeting, Minneapolis, MN, 2018. Medicine & Science in Sports & Exercise. 50: S703, 2018.
  • Ahn W, Hydock DS, Twaddle MD, Tigner AT, Wagner MK, and Bredahl EC. Effects of resistance training on antioxidant expression in type I muscle from doxorubicin treated rats. Poster Presentation, Experimental Biology Meeting, San Diego, CA, 2018. The Journal of the Federation of American Societies for Experimental Biology 32: S588.30, 2018.
  • Busekrus, RL, Hydock DS, Tigner A, Kaufenberg M, Hook S, Bredahl E. Effects of resistance exercise on kidney antioxidant enzymes of rats treated with doxorubicin. Poster Presentation, Experimental Biology Meeting, San Diego, CA, 2018. The Journal of the Federation of American Societies for Experimental Biology 32: LB351, 2018.
  • Jones ME, Busekrus RL, Torok ZA, Hydock DS. Effects of creatine supplementation and doxorubicin treatment on diaphragm myogenic regulatory factor expression. Poster Presentation, Experimental Biology Meeting, San Diego, CA, 2018. The Journal of the Federation of American Societies for Experimental Biology 32: S769.3, 2018.
  • Torok ZA, Busekrus RL, Hydock DS. Effects of creatine supplementation and doxorubicin treatment on myogenic regulatory factor expression in slow and fast muscle. Poster Presentation, Experimental Biology Meeting, San Diego, CA, 2018. The Journal of the Federation of American Societies for Experimental Biology 32: S769.1, 2018.
  • Busekrus RL, Capps MJ, Stewart LK, O’Brien K, Boenke C, Christensen M, Hydock DS. Effects of a Kefir Diet on Kidney Antioxidant Enzymes of Rats Treated with Doxorubicin. Poster Presentation, American College of Sports Medicine Annual Meeting, Denver, CO, 2017. Medicine & Science in Sports & Exercise. 49: S1015, 2017.
  • Capps MJ, Wood NR, Busekrus RB, Hydock DS. Effects of Doxorubicin Treatment and Exercise on Skeletal Muscle Function and Myogenic Regulatory Factors. Poster Presentation, American College of Sports Medicine Annual Meeting, Denver, CO, 2017. Medicine & Science in Sports & Exercise. 49: S773, 2017.
  • Torok ZT, Busekrus RB, Hydock DS. Effects of Creatine Supplementation on Doxorubicin-induced Myotoxicity. Thematic Poster Presentation. American College of Sports Medicine Annual Meeting, Denver, CO, 2017. Medicine & Science in Sports & Exercise. 49: S8, 2017.
  • Wood NR, Hayward R, Hydock DS. Effects of Endurance Training on Doxorubicininduced Changes in Cardiac Insulin-like Growth Factor-1 Expression. Poster Presentation, American College of Sports Medicine Annual Meeting, Denver, CO, 2017. Medicine & Science in Sports & Exercise. 49: S728, 2017.
  • Smoak P, Hayward R, Hydock DS, O’Brien K, Boenke C, Christensen M, Reeves K, Lisano J, Stewart JK. Kefir Alters Cardiac Function and Left Ventricular Dimensions in a Model of Doxorubicin-induced Cardiomyopathy. Poster Presentation, American College of Sports Medicine Annual Meeting, Denver, CO, 2017. Medicine & Science in Sports & Exercise. 49: S1024-25, 2017.
  • Kugler BA, Capps MJ, Hydock DS. Effects of Dietary Creatine Monohydrate Supplementation and Resistance Training on Late Onset Doxorubicin-Induced Skeletal Muscle Dysfunction and MyoD Expression. Poster Presentation, Experimental Biology Meeting, Chicago, IL, 2017. The Journal of the Federation of American Societies for Experimental Biology 31: LB745, 2017.
  • Hydock DS, Quinn CJ. Effects of Endurance Training and Doxorubicin on Hindlimb Muscle and Diaphragm Myogenic Regulatory Factors. Poster Presentation, American College of Sports Medicine Annual Meeting, Boston, MA, 2016. Medicine & Science in Sports & Exercise. 48: S277, 2016.
  • Borges RL, Hochberg LM, Bredahl EC, Hydock DS Pilot Study Examining the Effects of Doxorubicin Treatment and Voluntary Wheel Running on Kidney Antioxidants. Poster Presentation, American College of Sports Medicine Annual Meeting, Boston, MA, 2016. Medicine & Science in Sports & Exercise. 48: S143, 2016.
  • Bredahl EC, Hydock DS. Effects of Resistance Training and Creatine Monohydrate on Doxorubicin-Induced Muscle Fatigue. Poster Presentation, American College of Sports Medicine Annual Meeting, Boston, MA, 2016. Medicine & Science in Sports & Exercise. 48: S277, 2016.
  • Hochberg LM, Borges RL, Hydock DS. Effects of Voluntary Wheel Running During and Following Doxorubicin Treatment on Ex Vivo Skeletal Muscle Function. Poster Presentation, Experimental Biology Meeting, San Diego, CA, 2016. The Journal of the Federation of American Societies for Experimental Biology 30:1288.17, 2016.
  • Bredahl EC, Quinn CJ, Hayward R, Hydock DS. The Effects of Exercise on Antioxidants in Doxorubicin Treated Type 2 Muscle. Poster Presentation, American College of Sports Medicine Annual Meeting, San Diego, CA, 2015. Medicine & Science in Sports & Exercise. 47: S647, 2015.
  • Hydock DS, Omar A, Bredahl EC, Quinn CJ. In vivo Skeletal Muscle Function and Doxorubicin Treatment in the Rat. Poster Presentation, Experimental Biology Meeting, Boston, MA, 2015. The Journal of the Federation of American Societies for Experimental Biology 29: 1055.21, 2015.
  • Hydock DS, Bredahl EC, Quinn CJ, Hayward R. Protective Effects of Endurance or Resistance Training Exercise on Chemotherapy-Induced Skeletal Muscle Weakness and Fatigue. Poster Presentation, Experimental Biology Meeting, Boston, MA, 2015. The Journal of the Federation of American Societies for Experimental Biology 29: LB660, 2015.
  • Quinn CJ, Bredahl EC, Hayward R, Hydock DS. Effect of Doxorubicin Treatment on Myogenic Regulatory Factor Protein Expression in Skeletal Muscle. Poster Presentation, Experimental Biology Meeting, Boston, MA, 2015. The Journal of the Federation of American Societies for Experimental Biology 29: 826.9, 2015.
  • Hochberg L, Borges R, Bredahl EC, Quinn, CJ, Hydock DS. Effects of Voluntary Endurance Training on Skeletal Muscle Function During and Following Doxorubicin Treatment. Poster Presentation, Experimental Biology Meeting, Boston, MA, 2015. The Journal of the Federation of American Societies for Experimental Biology 29: 1055.26, 2015.
  • Hydock DS, Bredahl EC, Gibson NM, Quinn CJ, Hayward R. Correlations between skeletal muscle and cardiac function in exercised and sedentary rats receiving doxorubicin. Poster Presentation, American College of Sports Medicine Annual Meeting, Orlando, FL, 2014. Medicine & Science in Sports & Exercise. 46: S152, 2014
  • Quinn CJ, Elzaidi NM, Gibson NM, Bredahl EC, Hayward R, Hydock DS. Skeletal muscle SERCA expression following doxorubicin treatment: effects of exercise. Poster Presentation, American College of Sports Medicine Annual Meeting, Orlando, FL, 2014. Medicine & Science in Sports & Exercise. 46: S273, 2014.
  • Bredahl EC, Hydock DS. The effects of creatine incubation on doxorubicin-induced muscle dysfunction. Poster Presentation, American College of Sports Medicine Annual Meeting, Orlando, FL, 2014. Medicine & Science in Sports & Exercise. 46: S370, 2014.
  • Parry TL, Hydock DS, Schneider CM, Hayward R. Effect of exercise training on tumor growth and cardiac function in the rat cancer model. Poster Presentation, American College of Sports Medicine Annual Meeting, Orlando, FL, 2014. Medicine & Science in Sports & Exercise. 46: S511, 2014.
  • Hydock DS, Bredahl EC, Gibson, NM, Quinn, CJ, Hayward R. Differential effects of endurance training and resistance training on doxorubicin-induced skeletal muscle dysfunction. Poster Presentation, Experimental Biology Meeting, San Diego, CA, 2014. The Journal of the Federation of American Societies for Experimental Biology 28: 884.5, 2014.
  • Quinn C, Gibson N, Bashore A, Bredahl E, Hayward R, Hydock D. Effects of chronic exercise on doxorubicin-induced thymic damage. Poster Presentation, Experimental Biology Meeting, San Diego, CA, 2014. The Journal of the Federation of American Societies for Experimental Biology 28: 884.4, 2014.
  • Pfannenstiel K, Gibson NM, Quinn CJ, Hydock DS, Hayward R. Aging downregulates skeletal muscle multidrug resistance proteins and increases intramuscular doxorubicin accumulation. Poster Presentation, American College of Sports Medicine Annual Meeting, Indianapolis, IN, 2013. Medicine & Science in Sports & Exercise. 45: S17, 2013.
  • Parry TL, Greufe SE, Gibson NM, Hydock DS, Schneider CM, Hayward R. Cardiac dysfunction in the tumor bearing rat. Poster Presentation, American College of Sports Medicine Annual Meeting, Indianapolis, IN, 2013. Medicine & Science in Sports & Exercise. 45: S32, 2013.
  • Bredahl EC, Pfannenstiel KB, Greufe SE, Gibson NM, Quinn CJ, Schneider CM, Hayward R, Hydock DS. Effects of a resistance training model on doxorubicininduced muscle dysfunction in the rat. Poster Presentation, American College of Sports Medicine Annual Meeting, Indianapolis, IN, 2013. Medicine & Science in Sports & Exercise. 45: S150, 2013.
  • Greufe SE, Gibson NM, Frank AJ, Hydock DS, Schneider CM, Hayward R. Calorie restriction and voluntary exercise extend life span of rats treated with doxorubicin. Poster Presentation, American College of Sports Medicine Annual Meeting, Indianapolis, IN, 2013. Medicine & Science in Sports & Exercise. 45: S283, 2013
  • Gibson NM, Burns PD, Hydock DS, Schneider CM, Hayward R. Juvenile doxorubicin exposure increases cardiac progenitor cell expression in late-onset cardiotoxicities. Poster Presentation, American College of Sports Medicine Annual Meeting, Indianapolis, IN, 2013. Medicine & Science in Sports & Exercise. 45: S532, 2013.
  • Hydock DS, Bredahl E, Gibson N, Quinn C, Schneider CM, Hayward R. Endurance exercise and doxorubicin-induced skeletal muscle dysfunction. Poster Presentation, Experimental Biology Meeting, Boston, MA, 2013. The Journal of the Federation of American Societies for Experimental Biology 27: 712.27, 2013.
  • Quinn C, Gibson N, Bredahl E, Schneider C, Hayward R, Hydock D. Intramuscular doxorubicin accumulation and skeletal muscle fatigue: effects of prior exercise. Poster Presentation, Experimental Biology Meeting, Boston, MA, 2013. The Journal of the Federation of American Societies for Experimental Biology 27: 712.28, 2013.
  • Greufe SE, Gibson NM, Hydock DS, Schneider CM, Hayward R. Combined effects of streptozotocin and doxorubicin on cardiac function in rats. Poster Presentation, Experimental Biology Meeting, Boston, MA, 2013. The Journal of the Federation of American Societies for Experimental Biology 27: 701.8, 2013.
  • Gibson NM, Lien CY, Jensen BT, Hydock DS, Hayward R. A rat model of doxorubicin-induced late-onset cardiotoxicity. Poster Presentation, Experimental Biology Meeting, Boston, MA, 2013. The Journal of the Federation of American Societies for Experimental Biology 27: 1126.8, 2013.
  • Gibson NM, Pfannenstiel K, Quinn CJ, Hydock DS, Hayward R. Aging downregulates MRPs and increases cardiac doxorubicin accumulation. Poster Presentation, Experimental Biology Meeting, Boston, MA, 2013. The Journal of the Federation of American Societies for Experimental Biology 27: 1194.7, 2013.
  • Bredahl E, Hydock D, Iwaniec U, Turner R, Parry T, Schneider C, Hayward H. Effects of treadmill training on doxorubicin and goserelin acetate-induced bone degeneration. Poster Presentation, American Physiological Society Intersociety Meeting: The Integrative Biology of Exercise, Westminster, CO, 2012.
  • Gibson N, Greufe S, Hydock D, Hayward R. Effects of voluntary wheel running on aortic doxorubicin accumulation and dysfunction. Poster Presentation, American Physiological Society Intersociety Meeting: The Integrative Biology of Exercise, Westminster, CO, 2012.
  • Smith J, Yager J, Gibson N, Hydock D. A pilot study: effects of doxorubicin on hind-limb gait kinematics in rats. Poster Presentation, American Physiological Society Intersociety Meeting: The Integrative Biology of Exercise, Westminster, CO, 2012.
  • Kenefick K, Smith J, Bredahl E, Hydock D. Rat metabolic responses during treadmill running following doxorubicin injections in sedentary and exercise trained rats. Poster Presentation, American Physiological Society Intersociety Meeting: The Integrative Biology of Exercise, Westminster, CO, 2012.
  • Hydock DS, Lien CY, Jensen BT, Schneider CM, Hayward R. Effects of reduced dietary fat intake on doxorubicin cardiotoxicity in previously high fat fed rats. Thematic Poster Presentation, American College of Sports Medicine Annual Meeting, San Francisco, CA, 2012. Medicine & Science in Sports & Exercise. 44: S138, 2012.
  • Greufe SE, Gibson NM, Hydock DS, Schneider CM, Hayward R. Effects of calorie restriction and voluntary exercise on doxorubicin-induced cardiac dysfunction. Thematic Poster Presentation, American College of Sports Medicine Annual Meeting, San Francisco, CA, 2012. Medicine & Science in Sports & Exercise. 44: S138, 2012.
  • Lien CY, Hydock DS, Jensen BT, Schneider CM, Gibson NM, Cheng H, Hayward R. Effect of detraining on doxorubicin-induced cardiac dysfunction. Thematic Poster Presentation, American College of Sports Medicine Annual Meeting, San Francisco, CA, 2012. Medicine & Science in Sports & Exercise. 44: S139, 2012.
  • Gibson NM, Hydock DS, Greufe SE, Schneider CM, Hayward R. Time course of doxorubicin accumulation and dysfunction in left ventricular tissue. Thematic Poster Presentation, American College of Sports Medicine Annual Meeting, San Francisco, CA, 2012. Medicine & Science in Sports & Exercise. 44: S139, 2012.
  • Bredahl EC, Gibson NM, Greufe SE, Pfannenstiel KB, Parry TL, Schneider CM, Hayward R, Hydock DS. Intramuscular doxorubicin accumulation and skeletal muscle dysfunction. Poster Presentation, American College of Sports Medicine Annual Meeting, San Francisco, CA, 2012. Medicine & Science in Sports & Exercise. 44: S502, 2012.
  • Parry TL, Iwaniec UT, Turner RT, Lien CY, Jensen BT, Hydock DS, Schneider CM, Hayward R. Voluntary wheel running does not protect against doxorubicin-induced osteopenia in the growing rat. Poster Presentation, American College of Sports Medicine Annual Meeting, San Francisco, CA, 2012. Medicine & Science in Sports & Exercise. 44: S524, 2012.
  • Shackleford DY, Brown JM, Lalonde TL, Hydock DS, Schneider CM. Validation of the Rocky Mountain Cancer Rehabilitation Institute Multistage Treadmill Protocol for cancer survivors. Poster Presentation, American College of Sports Medicine Annual Meeting, San Francisco, CA, 2012. Medicine & Science in Sports & Exercise. 44: S553, 2012.
  • Gibson NM, Hydock DS, Hayward R. Time course of doxorubicin accumulation and dysfunction in the rat aorta. Slide Presentation, Experimental Biology Meeting, San Diego, CA, 2012. The Journal of the Federation of American Societies for Experimental Biology. 26: 866.9, 2012
  • Hydock DS, Lien CY, Jensen BT, Parry TL, Schneider CM, Hayward R. Effects of In Vivo Doxorubicin Treatment on Skeletal Muscle Function. Poster Presentation, American College of Sports Medicine Annual Meeting, Denver, CO, 2011. Medicine & Science in Sports & Exercise. 43: S628, 2011.
  • Jensen BT, Hydock DS, Lien CY, Schneider CM, Hayward R. Effect of Exercise Preconditioning on Doxorubicin Accumulation in Left Ventricular Tissue. Slide Presentation, American College of Sports Medicine Annual Meeting, Denver, CO, 2011. Medicine & Science in Sports & Exercise. 43: S113, 2011.
  • Weiderspon JM, Repka, CP, Dallow K, Hayward R, Hydock DS, Schneider CM. Normalization of cardiovascular fitness in cancer survivors following an exercise intervention. Poster Presentation, American College of Sports Medicine Annual Meeting, Denver, CO, 2011. Medicine & Science in Sports & Exercise. 43: S386, 2011.
  • Greufe SE, Cheng HW, Repka CP, Hayward R, Hydock DS, Schneider CM. The effect of cancer stage on physiological and psychological parameters following supervised exercise training. Poster Presentation, American College of Sports Medicine Annual Meeting, Denver, CO, 2011. Medicine & Science in Sports & Exercise. 43: S387, 2011.
  • Parry TL, Hydock DS, Jensen BT, Lien CY, Schneider CM, Hayward R. Endurance exercise attenuates cardiotoxicity induced by androgen deprivation and doxorubicin. Poster Presentation, American College of Sports Medicine Annual Meeting, Denver, CO, 2011. Medicine & Science in Sports & Exercise. 43: S456, 2011.
  • Lien CY, Hydock DS, Jensen BT, Schneider CM, Hayward R. Voluntary exercise attenuates doxorubicin-induced chronic cardiotoxicity in juvenile rats. Poster Presentation, American College of Sports Medicine National Meeting, Denver, CO, 2011. Medicine & Science in Sports & Exercise. 43: S456, 2011.
  • Hydock DS, Lien CY, Jensen BT, Parry TL, Malcolm WT, Schneider CM, Hayward R. Concurrent wheel running and weekly doxorubicin treatment in the rat: effects on cardiac function. Slide Presentation, American College of Sports Medicine Annual Meeting, Baltimore, MD, 2010. Medicine & Science in Sports & Exercise. 42: S3, 2010.
  • Lien CY, Hydock DS, Jensen BT, Zhang H, Schneider CM, Hayward R. Use of combined preconditioning and rehabilitative exercise to alleviate chronic doxorubicin cardiotoxicity. Slide Presentation, American College of Sports Medicine Annual Meeting, Baltimore, MD, 2010. Medicine & Science in Sports & Exercise. 42: S3, 2010.
  • Jensen BT, Lin YK, Hydock DS, Lien CY, Takach OP, Schneider CM, Hayward R. Use of a discriminant analysis model to evaluate to protective effect of exercise against DOX mediated cardiotoxicity. Slide Presentation, American College of Sports Medicine Annual Meeting, Baltimore, MD, 2010. Medicine & Science in Sports & Exercise. 42: S3, 2010
  • Parry TL, Hydock DS, Jensen BT, Lien CY, Schneider CM, Hayward R. Effects of endurance training on cardiotoxicity induced by combined treatment with doxorubicin and goserelin acetate. Thematic Poster Presentation, American College of Sports Medicine Annual Meeting, Baltimore, MD, 2010. Medicine & Science in Sports & Exercise. 42: S119, 2010.
  • Greufe SE, Wonders KY, Hydock DS, Schneider CM, Hayward R. Effects of exercise training on cardiac caspase expression in rats receiving doxorubicin and GW2974. Poster Presentation, American College of Sports Medicine Annual Meeting, Baltimore, MD, 2010. Medicine & Science in Sports & Exercise. 42: S449, 2010.
  • Sprod LK, Hayward R, Hydock DS, Schneider CM. Using Risk Level to Guide Breast Cancer Risk Reduction and Screening Recommendations. Society of Behavioral Medicine. Seattle, WA, 2010.
  • Hydock DS, Lien CY, Jensen BT, Parry TL, Schneider CM, Hayward R. Cardioprotective effects of voluntary wheel running during and following doxorubicin treatment. Slide Presentation, American College of Sports Medicine Annual Meeting, Seattle, WA, 2009. Medicine & Science in Sports & Exercise. 41: S118, 2009.
  • Lien CY, Hydock DS, Jensen BT, Schneider CM, Hayward R. Effects of exercise preconditioning against doxorubicin cardiotoxicity are affected by exercise modality and doxorubicin dose. Slide Presentation, American College of Sports Medicine Annual Meeting, Seattle, WA, 2009. Medicine & Science in Sports & Exercise. 41: S118, 2009.
  • Jensen BT, Hydock DS, Lien CY, Parry TL, Schneider CM, Hayward R. Effects of low vs. high intensity short-term exercise on doxorubicin-induced cardiotoxicity. Slide Presentation, American College of Sports Medicine Annual Meeting, Seattle, WA, 2009. Medicine & Science in Sports & Exercise. 41: S84, 2009
  • Parry TL, Wilkerson, G, Hydock DS, Jensen BT, Lien CY, Schneider CM, Hayward R. Histological evaluation of doxorubicin-induced cardiotoxicity in exercise trained rats. Poster Presentation, American College of Sports Medicine Annual Meeting, Seattle, WA, 2009. Medicine & Science in Sports & Exercise. 41: S218, 2009.
  • Hydock DS, Lien CY, Jensen BT, Schneider CM, Hayward R. Late onset doxorubicin-induced cardiac dysfunction is attenuated in exercise preconditioned rats. Slide Presentation, American College of Sports Medicine Annual Meeting, Indianapolis, IN, 2008. Medicine & Science in Sports & Exercise. 40: S95, 2008.
  • Lien CY, Hydock DS, Jensen BT, Schneider CM, Hayward R. Low-intensity, lowfrequency exercise protects against DOX-induced cardiac dysfunction in rats. Slide Presentation, American College of Sports Medicine Annual Meeting, Indianapolis, IN, 2008. Medicine & Science in Sports & Exercise. 40: S94, 2008.
  • Jensen BT, Hydock DS, Lien CY, Schneider CM, Hayward R. Effects of short-term exercise on doxorubicin-induced cardiotoxicity. Slide Presentation, American College of Sports Medicine Annual Meeting, Indianapolis, IN, 2008. Medicine & Science in Sports & Exercise. 40: S95, 2008.
  • Parry TL, Hydock DS, Iwaniec UT, Turner RT, Lien CY, Jensen BT, Hayward R. Effects of goserelin acetate and voluntary wheel running on bone morphology in female rats. Slide Presentation, American College of Sports Medicine Annual Meeting, Indianapolis, IN, 2008. Medicine & Science in Sports & Exercise. 40: S82, 2008.
  • Repka CP, Sprod LK, Hsieh CC, Hydock DS, Carter SD, Hayward R, Schneider CM. Health-related fitness and quality of life in cancer survivors. Slide Presentation, American College of Sports Medicine Annual Meeting, Indianapolis, IN, 2008. Medicine & Science in Sports & Exercise. 40: S113, 2008.
  • Hydock DS, Lien CY, Schneider CM, Hayward R. Effects of voluntary wheel running on cardiac function in female rats receiving chemical ovariectomy. Slide Presentation, American College of Sports Medicine Annual Meeting, New Orleans, LA, 2007. Medicine & Science in Sports & Exercise. 39: S53, 2007.
  • Hayward R, Lien CY, Schneider CM, Hydock DS. Effects of prior endurance training on acute doxorubicin-induced cardiotoxicity. Slide Presentation, American College of Sports Medicine Annual Meeting, New Orleans, LA, 2007. Medicine & Science in Sports & Exercise. 39: S53, 2007
  • Wonders KY, Greufe SE, Hydock DS, Schneider CM, Hayward R. Effects of endurance training on cardiac function in rats receiving GW2974 and doxorubicin. Slide Presentation, American College of Sports Medicine Annual Meeting, New Orleans, LA, 2007. Medicine & Science in Sports & Exercise. 39: S64, 2007.
  • Hydock DS, Wonders KY, Schneider CM, Hayward R. Endurance training protects against prostate cancer treatment-induced cardiac dysfunction. Slide Presentation, American College of Sports Medicine Annual Meeting, Denver, CO, 2006. Medicine and Science in Sports and Exercise. 38: S83, 2006.
  • Wonders KY, Hydock DS, Greufe SE, Schneider CM, Hayward R. Effects of doxorubicin and EGFR/ErbB2 inhibitors on cardiac function. Poster Presentation, American College of Sports Medicine Annual Meeting, Denver, CO, 2006. Medicine and Science in Sports and Exercise. 38: S534, 2006.
  • Lien CY, Wonders KY, Hydock DS, Schneider CM, Hayward R. Time course of cardiac function and oxidative stress induced by an acute bout of exercise. Poster Presentation, American College of Sports Medicine Annual Meeting, Denver, CO, 2006. Medicine and Science in Sports and Exercise. 38: S419, 2006.
  • Hydock DS, Wonders KY, Chicco AJ, Schneider CM, Hayward R. Voluntary wheel running in rats receiving doxorubicin treatment: Effects on myosin heavy chain. Poster Presentation, American College of Sports Medicine Annual Meeting, Nashville, TN, 2005. Medicine and Science in Sports and Exercise 37: S439, 2005.
  • Roozeboom MA, Carter SD, Hydock DS, Schneider CM. Muscular strength and endurance alterations in cancer patients. Slide Presentation, American College of Sports Medicine Annual Meeting, Indianapolis, IN, 2004. Medicine and Science in Sports and Exercise 36: S98, 2004.
  • Hydock DS, Carter SD, Drum SN, Roozeboom MA, Schaffer JR, Hayward R, Schneider CM. The exercise response is patient specific, not cancer specific. Slide Presentation, American College of Sports Medicine Annual Meeting, San Francisco, CA, 2003. Medicine and Science in Sports and Exercise 35: S398, 2003.
  • Drum SN, Carter SD, Roozeboom MA, Hydock DS, Schaffer JR, Knofczynski GT, Hayward R, Schneider CM. Exercise intervention and the effect on cancer patients. Slide Presentation, American College of Sports Medicine Annual Meeting, San Francisco, CA, 2003. Medicine and Science in Sports and Exercise 35: S398, 2003.
  • Jones BC, Hydock DS, The effect of gonadotropin releasing hormone agonist treatment as a puberty blocker on physical activity in young rats. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Golden, CO, 2022.
  • Sharif S, Hydock DS, Daehlin KA, Twaddell MD, Tigner AT, Wagner MK, Bredahl EC. Resistance exercise and doxorubicin treatment: effects on antioxidant enzyme expression in type II muscle. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Denver, CO, 2019.
  • Sharif S, Hydock DS, Twaddell MD, Tigner AT, Wagner MK, Bredahl EC. Effects of Resistance Training and Doxorubicin on Creatine Transporter and Creatine Kinase Expression in Fast Muscle. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Colorado Springs, CO, 2018.
  • Busekrus RB, Capps CJ, Stewart LK, O’brien K, Boenke C, Christensen M, Hydock DS. Effects of a kefir diet on kidney antioxidant enzymes of rats treated with doxorubicin. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Greeley, CO, 2017.
  • Capps CJ, Wood NR, Busekrus RB, Hydock DS. Effects of doxorubicin treatment and exercise on skeletal muscle function and myogenic regulatory factors. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Greeley, CO, 2017.
  • Kugler BA, Capps MJ, Busekrus RB, Mathias A, Hydock DS. Effects of dietary creatine monohydrate supplementation on late onset doxorubicin-induced skeletal muscle dysfunction. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Greeley, CO, 2017.
  • Torok ZA, Busekrus RB, Hydock DS. Effects of creatine supplementation on doxorubicin-induced myotoxicity. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Greeley, CO, 2017.
  • Wood NR, Hayward, Hydock DS. Effects of endurance exercise training on doxorubicin-induced changes in cardiac insulin-like growth factor-1 expression. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Greeley, CO, 2017.
  • Bredahl EC, Hydock DS. The effects of creatine incubation on doxorubicin-induced muscle dysfunction. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Denver, CO, 2014.
  • Parry TL, Hydock DS, Hayward R. Effect of aerobic exercise training on cancer induced cardiac dysfunction. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Denver, CO, 2014
  • Bredahl EC, Pfannenstiel KB, Greufe SE, Gibson NM, Quinn CJ, Schneider CM, Hayward R, Hydock DS. Effects of a resistance training model on doxorubicininduced muscle dysfunction in the rat. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Denver, CO, 2013.
  • Parry TL, Greufe SE, Gibson NM, Hydock DS, Schneider CM, Hayward R. Cardiac Dysfunction in the tumor bearing rat. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Denver, CO, 2013.
  • Gibson NM, Burns PD, Hydock DS, Schneider CM, Hayward R. Juvenile doxorubicin exposure increases cardiac progenitor cell expression in late-onset cardiotoxicities. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Denver, CO, 2013.
  • Bredahl EC, Gibson NM, Greufe SE, Pfannenstiel KB, Parry TL, Schneider CM, Hayward R, Hydock DS. Intramuscular doxorubicin accumulation and skeletal muscle dysfunction. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Colorado Springs, CO, 2012.
  • Greufe SE, Gibson NM, Hydock DH, Schneider CM, Hayward R. Effects of calorie restriction and voluntary exercise on doxorubicin-induced cardiac dysfunction. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Colorado Springs, CO, 2012.
  • Parry TL, Iwaniec UT, Turner RT, Lien CY, Jensen BT, Hydock DS, Schneider CM, Hayward R. Voluntary wheel running does not protect against doxorubicin-induced osteopenia in the growing rat. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Colorado Springs, CO, 2012.
  • Shackleford DY, Brown JM, Lalonde TL, Hydock DS, Schneider CM. Validation of the Rocky Mountain Cancer Rehabilitation Institute Multistage Treadmill Protocol for cancer survivors. Poster Presentation, Rocky Mountain American College of Sports Medicine Annual Meeting, Colorado Springs, CO, 2012.
  • Parry TL, Hydock DS, Jensen, BT, Lien CY, Schneider CM, Hayward R. Endurance exercise attenuates cardiotoxicity induced by androgen deprivation and doxorubicin. Poster and Slide Presentation, Rocky Mountain American College of Sports Medicine Regional Meeting, Fort Collins, CO, 2011.
  • Weiderspon JM, Repka CP, Dallow K, Hayward R, Hydock DS, Schneider CM. Normalization of cardiovascular fitness in cancer survivors following an exercise intervention. Poster Presentation, Rocky Mountain American College of Sports Medicine Regional Meeting, Fort Collins, CO, 2011.
  • Jensen BT, Hydock DS, Lien CY, Schneider CM, Hayward R. Effects of short-termexercise on doxorubicin-induced cardiotoxicity. Poster Presentation, Rocky Mountain American College of Sports Medicine Regional Meeting, Estes Park, CO, 2008.
  • Lien CY, Hydock DS, Jensen BT, Schneider CM, Hayward R. Low-intensity, lowfrequency exercise protects against DOX-induced cardiac dysfunction in rats. Poster Presentation, Rocky Mountain American College of Sports Medicine Regional Meeting, Estes Park, CO, 2008.
  • Parry T, Hydock DS, Iwaniec UT, Turner RT, Lien CY, Jensen BT, Hayward R. Effects of goserelin acetate and voluntary wheel running on bone morphology in female rats. Poster Presentation, Rocky Mountain American College of Sports Medicine Regional Meeting, Estes Park, CO, 2008.
  • Repka CP, Sprod LK, Hsieh CC, Hydock DS, Carter, SD, Hayward, R, Schneider, CM. Health-related fitness and quality of life in cancer survivors. Poster Presentation, Rocky Mountain American College of Sports Medicine Regional Meeting, Estes Park, CO, 2008.
  • Jensen BT, Hydock DS, Schneider CM, Hayward R. Endurance training protects against ex vivo doxorubicin induced cardiotoxicity four weeks post administration. Poster Presentation, Rocky Mountain American College of Sports Medicine Regional Meeting, Colorado Springs, CO, 2007.
  • Lien CY, Hydock DS, Schneider CM, Hayward R. Endurance training protects against in vivo and ex vivo doxorubicin cardiotoxicity. Poster Presentation, Rocky Mountain American College of Sports Medicine Regional Meeting, Colorado Springs, CO, 2007.
  • Wonders KY, Hydock DS, Hayward R. Acute exercise and cardiac dysfunction. Poster and Slide Presentation, Rocky Mountain American College of Sports Medicine Regional Meeting, Estes Park, CO, 2006.
  • Hydock DS, Wonders KY, Chicco AJ, Schneider CM, Hayward R. Voluntary wheel running in rats receiving doxorubicin treatment: effects on myosin heavy chain. Poster and Slide Presentation, American College of Sports Medicine Rocky Mountain Chapter Regional Meeting, Colorado Springs, CO, 2005.
  • Hydock DS, Carter SD, Drum SN, Roozeboom MA, Schaffer JR, Hayward R, Schneider CM. The exercise response is patient specific, not cancer specific. Poster Presentation, American College of Sports Medicine Rocky Mountain Chapter Regional Meeting, Denver, CO, 2003.
  • Hydock DS. Transgender Physical Activity. School of Sport and Exercise Science Colloquium, University of Northern Colorado. Greeley, CO, 2021
  • Hydock DS. Cancer Treatment Toxicities: Using Exercise and Nutrition to Battle Side Effects. Cancer Progress and Breakthroughs, American Cancer Society Stewardship Event. Loveland, CO, 2020
  • Hydock DS. Cancer Treatment Toxicities: Using Exercise and Nutrition to Battle Side Effects. Past President’s Lecture, Rocky Mountain American College of Sport Medicine Annual Meeting. Denver, CO, 2019.
  • Hydock DS. Creatine supplementation in managing doxorubicin-induced muscle fatigue. Work-In-Progress Presentation, 12th Annual Kathleen Foley Palliative Care Retreat. La Jolla, CA, 2018
  • Hydock DS. Creatine supplementation in managing doxorubicin-induced muscle fatigue. American Cancer Society Relay for Life Kickoff, Loveland, CO, 2018
  • Hydock DS. Exercise and cancer treatment-related side effects. American Cancer Society Relay for Life Kickoff, Brighton, CO, 2015
  • Hydock DS. Exercise and cancer treatment-related side effects. American Cancer Society-Weld County Leadership Council, Greeley, CO, 2014
  • Hydock DS. Cancer treatment toxicities and exercise. American Cancer SocietyWyoming Chapter Day of Hope Meeting, Cheyenne, WY, 2014
  • Hydock DS. Exercise and cancer treatment-related side effects (community lecture). American Cancer Society Relay for Life Kickoff, Fort Collins, CO, 2013
  • Hydock DS. Exercise and cancer treatment-related side effects (professional lecture) and cancer rehabilitation (community lecture). Annual Elsa U. Pardee Memorial Cancer Lecture, MidMichigan Medical Center, Midland, MI, 2011
  • Hydock DS. Exercise and cancer treatment-related side effects. Colorado State University, Department of Health and Exercise Science seminar. Fort Collins, CO, 2010
  • Hydock DS. Implementing functional resistance training into a cancer rehabilitation exercise prescription. Rocky Mountain Cancer Rehabilitation Institute Cancer Exercise Specialist Workshop. Greeley, CO, 2005, 2006, and 2008.
  • Hydock DS. Exercise and cancer treatment-induced cardiac dysfunction. University of Minnesota Medical School, Duluth seminar. Duluth, MN, 2008.
  • Hydock DS. Periodization of strength training: implementing a performance-based approach. Five Star Strength and Conditioning Clinic. Westminster, CO, 2008.
  • Hydock DS. Exercise and cancer treatment-induced cardiac dysfunction. Rocky Mountain Cancer Rehabilitation Institute Cancer Exercise Specialist Workshop. Greeley, CO, 2007.
  • Hydock DS. Side effects of androgen deprivation therapy in prostate cancer patients. University of Northern Colorado Community Health 560 course (Scientific Foundations of Health Promotion/Disease Prevention), Greeley, CO, 2004.
  • Hydock DS. Side effects of androgen deprivation therapy in prostate cancer patients. North Colorado Medical Center Man to Man Prostate Cancer Support Group, Greeley, CO, 2003.
  • Hydock DS. Rocky Mountain Cancer Rehabilitation Institute Program Overview. North Colorado Medical Center Man to Man Prostate Cancer Support Group, Greeley, CO, 2002.
  • Hydock DS. The weightlifting pull in power development. University of North Dakota Strength and Conditioning Clinic, Grand Forks, ND, 2001.
  • Hydock DS. Teaching progression for the jerk. National Strength and Conditioning Association North and South Dakota Combined State Clinic, Bismarck, ND, 1998.
  • Hydock DS. Teaching progression for the snatch and clean. National Strength and Conditioning Association North and South Dakota Combined State Clinic, Fargo, ND, 1997.
  • Jones BC, Hydock DH. Effects of puberty blocker treatment on physical activity in female and male rats.
  • Torok ZA, Busekrus RL, Hydock DS. Effects of creatine feeding on doxorubicininduced apoptosis in skeletal muscle.
  • Busekrus RL, Capps MJ, Bredahl EC, Hydock DS. Effects of creatine and doxorubicin on kidney antioxidant expression.
  • Sharif S, Busekrus RB, Torok ZA, Jones BC, Hydock DS. Beyond performance: creatine delays the onset of fatigue and augments muscle regeneration in doxorubicin-induced myotoxicity.
  • Wong D, Hydock DS, Babkes Stellino M. Cisgender and transgender college student self-reported physical activity: examination of differences and relationships to mental health.

Grants and Sponsored Research

  • Hydock, D. S., “Effects or maternal and paternal physical activity during puberty blocking on offspring physical activity levels,” Sponsored by Provost Research, Dissemination, and Faculty Development Award, University of Northern Colorado, $7,847.00. (April 2024 – July 2026).
  • Hydock DS. Be KiND: Student Success in the New School of Kinesiology, Nutrition, and Dietetics. Improvement Project Grant, University of Northern Colorado Graduation and Retention Taskforce, $5,000, summer 2022.
  • Hydock DS. Puberty blocker and de-transition effects on reproductive and liver health. University of Northern Colorado Provost Seed Grant, $14,300, spring 2022.
  • Hydock DS. Puberty blockers and female reproductive health. University of Northern Colorado CARES Act Stimulus Funds for RSCW, $9,510, 2021.
  • Hydock DS, Burns P, Han, Y. Puberty Blockers, Discontinuation, and Female Reproductive Health. University of Northern Colorado Faculty Research and Publications Board New Project Program. $3,979, fall 2020.
  • Hydock DS (PI). Long-term puberty blocker treatment and physical activity: Implications for transgender youth. University of Northern Colorado Provost Research, Dissemination, and Faculty Development Award. $7,958, fall 2019.
  • Hydock DS (PI). Creatine supplementation in managing doxorubicin-induced muscle fatigue. American Cancer Society, Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families, $139,000, 2018-2019.
  • Hydock DS (PI). Effects of endurance training and resistance training alone or in combination on doxorubicin myotoxicity. University of Northern Colorado Faculty Research and Publications Board New Project Program. $5,000, fall 2016.
  • Hydock DS (PI). Effects of creatine supplementation on doxorubicin-induced muscle weakness and fatigue. University of Northern Colorado Provost Research, Dissemination, and Faculty Development Award. $9,912, spring 2015
  • Hydock DS. RMACSM Student Development Grant. American College of Sports Medicine Regional Chapter Grant Program. $2,000, 2015.
  • Frietze SE (PI), Lerach DG (Co-PI), Hydock DS (Co-PI), Mostowfi M (Co-PI), Flynn WJ (Co-PI). Acquisition of a high performance computing cluster for multidisciplinary research and education at the University of Northern Colorado. National Science Foundation Major Research Instrumentation Program, $139,948, 2014-2017.
  • Hydock DS (PI). Effects of exercise on muscle weakness and fatigue during and following doxorubicin treatment. University of Northern Colorado Faculty Research and Publications Board New Project Program. $4,989, spring 2014.
  • Hydock DS (PI). Doxorubicin treatment and skeletal muscle function: effects of exercise. American Cancer Society Mentored Research Scholar Grant (Mentor: Hayward R), $421,000, 2012-2015.
  • Hydock DS (PI). Effects of exercise on doxorubicin-induced skeletal muscle dysfunction. University of Northern Colorado Provost Research, Dissemination, and Faculty Development Award. $9,571, spring 2011.
  • Smith JD (PI), Heise GD (Co-PI), Hydock DS (Co-PI), Schneider CM (Co-PI). Acquisition of a motion and force analysis system for research and research training related to biomechanical deficits, National Science Foundation Major Research Instrumentation Program, $242,905, 2011-2014.
  • Hydock DS (PI). Effects of reduced dietary fat intake on doxorubicin cardiotoxicity in obese rats. University of Northern Colorado Provost Research, Dissemination, and Faculty Development Award. $9,985, fall 2009.
  • Hydock DS (PI). Effects of in vivo doxorubicin treatment on skeletal muscle function. University of Northern Colorado Faculty Research and Publications Board New Project Program, $2,374 fall 2009.
  • Hydock DS, Hayward R. Effects of Zoladex treatment on doxorubicin cardiotoxicity: can treadmill training alleviate cardiac dysfunction? AstraZeneca Inc. $61,600, summer 2008
  • Hydock DS, Hayward R. Effects of voluntary exercise on Zoladexinduced cardiac dysfunction in male and female rats. AstraZeneca Inc. $28,000, spring 2006.
  • Hydock DS, Hayward, R. Can exercise training attenuate the deleterious effects of androgen deprivation therapy? AstraZeneca Inc. $18,200, summer 2004.